Literature DB >> 18428

Studies of binding C3-substitute rifamycins to human and bovine serum albumin.

A Assandri, A Perazzi, M Berti.   

Abstract

The interactions of a series of C3-substituted rifamycins with human and bovine serum albumins were studied in order to find possible correlations between the degree of binding and the structural features of the various molecules. The results obtained indicate some of the physicochemical properties and, therefore, of the structural requirements which appear to determine or influence the bonding mechanisms of this series of rifamycins. Two types of interaction were found to exist, ionic and hydrophobic types. The findings suggest that the inhibition by protein of the antibacterial activities of these antibiotics depends on the type of bonding mechanism rather than the degree of binding.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 18428     DOI: 10.7164/antibiotics.30.409

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  3 in total

1.  Antibacterial activity of DL 473, a C3-substituted rifamycin derivative.

Authors:  H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1983-09       Impact factor: 5.191

2.  Systemic absorption of rifamycin SV MMX administered as modified-release tablets in healthy volunteers.

Authors:  A F D Di Stefano; A Rusca; L Loprete; M J Dröge; L Moro; A Assandri
Journal:  Antimicrob Agents Chemother       Date:  2011-03-14       Impact factor: 5.191

3.  In Vitro Assessment of Uptake and Lysosomal Sequestration of Respiratory Drugs in Alveolar Macrophage Cell Line NR8383.

Authors:  Ayşe Ufuk; Graham Somers; J Brian Houston; Aleksandra Galetin
Journal:  Pharm Res       Date:  2015-07-30       Impact factor: 4.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.